By Associated Press
October is prime time for flu vaccinations, and the U.S. and Europe are gearing up for what experts hope is high demand as countries seek to avoid a “twindemic” with COVID-19.
“There’s considerable concern as we enter the fall and winter months and into the flu season that we’ll have that dreaded overlap” of flu and the coronavirus, Dr. Anthony Fauci of the U.S. National Institutes of Health said Thursday. He got his own flu shot earlier this week.
A record number of flu vaccine doses are on the way, between 194 million and 198 million for the U.S. alone — seemingly plenty considering last year just under half of adults got vaccinated and there usually are leftovers.
Still, there’s no way to know how many will seek shots this year and some people occasionally are finding drugstores or clinics temporarily out of stock.
This is how much it costs to develop a vaccine
As the race to create a COVID-19 vaccine continues, here are the expenses that typically go into creating and distributing vaccines.
Be patient: Flu vaccine ships gradually. Less than half has been distributed so far, and the CDC and manufacturers say more is in transit.
“This year I think everyone is wanting to get their vaccine and maybe wanting it earlier than usual,” Dr. Daniel Jernigan of the Centers for Disease Control and Prevention told The Associated Press. “If you’re not able to get your vaccination now, don’t get frustrated” but keep trying.
Pharmaceutical giant Sanofi Pasteur, which is supplying nearly 250 million doses worldwide including 80 million for the U.S., says it has shipments staggered into November.
Vaccine maker Seqirus is exploring if it could squeeze out “a limited number of additional doses” to meet high demand, said spokeswoman Polina Miklush.
Brewing flu vaccine is time-consuming. Once production ends for the year, countries can’t simply order more — making for a stressful balancing act as they guess how many people will roll up their sleeves.
Germany usually buys 18 million to 19 million doses, and this year ordered more. As German Health Minister Jens Spahn put it: “If we manage, together, to get the flu vaccination rate so high that all 26 million doses are actually used, then I’d be a very happy health minister.”
Spain purchased extra doses in hopes of vaccinating far more older adults and pregnant women than usual, along with key workers in health facilities and nursing homes.
In contrast, Poland, which last year had 100,000 doses go unused, didn’t anticipate this fall’s high demand and is seeking more.